ClinicalTrials.gg
DrugCombination product

Ciliary Neurotrophic Factor clinical trials

Also written NT-501.

studies test it
17
open now
1
in phase 3
2
first study started
2003

How each study uses Ciliary Neurotrophic Factor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ciliary Neurotrophic Factor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

NT-501 CNTF Implant
3
Ciliary neurotrophic factor (CNTF)
2
CNTF implant
2

Development codes

NT-501
5

Studies by the year they started

17 studies that test it; most in 2007 (3)

Studies that test Ciliary Neurotrophic Factor, by start year
YearStudies
20031
20073
20113
20122
20141
20161
20172
20181
20212
20251

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
10
Phase 3
2
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 6

Neurotech Pharmaceuticals (11) · Stanford University (2) · National Eye Institute (NEI) (2) · Jeffrey L Goldberg (2)

Often tested with

Tested in the same studies.

Revakinagene taroretcel (1)

Studies

Open first, then newest update. How each study uses Ciliary Neurotrophic Factor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17